John T. Koh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
John T. Koh has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Youheng Shi
Department of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716
4 shared publicationsA. Quamrul Hassan
Department of Chemistry and Biochemistry, University of Delaware, Newark, DE 19716 (USA)
3 shared publications- John B. Biggins
Laboratory of Genetically Encoded Small Molecules, Howard Hughes Medical Institute, The Rockefeller University, New York, New York, USA
3 shared publications Atsushi Hashimoto
Department of Chemistry and Biochemistry, University of Delaware, Brown Laboratories, Newark, DE 19716, USA, Fax: (+1) 302‐831‐6335
2 shared publicationsKristian H. Link
Department of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716
2 shared publicationsLuke M. Ceo
Department of Chemistry and Biochemistry, University of Delaware, Brown Laboratories, USA
2 shared publications
Latest Publications
- Open Access
- 27 August 2022
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 72, 116973
Catalytic covalent inhibition of cyclooxygenase-1 by a biomimetic acyltransferase
- 27 August 2022
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 72, 116973
Open AccessCatalytic covalent inhibition of cyclooxygenase-1 by a biomimetic acyltransferase
- 22 August 2016
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 11 (10) , 2797-2802
Antagonizing the Androgen Receptor with a Biomimetic Acyltransferase
The Androgen Receptor (AR) remains the leading target of advanced prostate cancer therapies. Thiosalicylamide analogs have previously been shown to act in cells as acyltransfer catalysts that are capable of transferring cellular acetate, presumably from acetyl-CoA, to HIV NCp7. Here we explore if the cellular acetyl-transfer activity of thiosalicylamides can be redirected to other cellular targets guided by ligands for AR. We constructed conjugates of thiosalicylamides and the AR-binding small molecule tolfenamic acid, which binds the BF-3 site of AR, proximal to the coactivator “FXXLF” binding surface. The thiosalicylamide-tolfenamic acid conjugate, YZ03, but not the separate thiosalicylamide plus tolfenamic acid, significantly enhanced acetylation of endogenous AR in CWR22Rv1 cells. Further analysis confirms that Lys720, a residue critical to FXXLF coactivator peptide binding, is a site of acyl-YZ03 acetylation. Under acyl-transfer conditions, YZ03 significantly enhances the ability of BF-3 site binding ligands to inhibit AR-coactivator peptide association. These data suggest that biomimetic acyltransferases can enhance protein–protein interaction inhibitors through covalent modification of critical interfacial residues.
- 22 August 2016
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 11 (10) , 2797-2802
Antagonizing the Androgen Receptor with a Biomimetic Acyltransferase
The Androgen Receptor (AR) remains the leading target of advanced prostate cancer therapies. Thiosalicylamide analogs have previously been shown to act in cells as acyltransfer catalysts that are capable of transferring cellular acetate, presumably from acetyl-CoA, to HIV NCp7. Here we explore if the cellular acetyl-transfer activity of thiosalicylamides can be redirected to other cellular targets guided by ligands for AR. We constructed conjugates of thiosalicylamides and the AR-binding small molecule tolfenamic acid, which binds the BF-3 site of AR, proximal to the coactivator “FXXLF” binding surface. The thiosalicylamide-tolfenamic acid conjugate, YZ03, but not the separate thiosalicylamide plus tolfenamic acid, significantly enhanced acetylation of endogenous AR in CWR22Rv1 cells. Further analysis confirms that Lys720, a residue critical to FXXLF coactivator peptide binding, is a site of acyl-YZ03 acetylation. Under acyl-transfer conditions, YZ03 significantly enhances the ability of BF-3 site binding ligands to inhibit AR-coactivator peptide association. These data suggest that biomimetic acyltransferases can enhance protein–protein interaction inhibitors through covalent modification of critical interfacial residues.
- 23 January 2012
- Published by Wiley in ChemBioChem
- Vol. 13 (4) , 511-513
Photocaged DNA Provides New Levels of Transcription Control
Spot lit: Photocaged nucleic acids have been used to regulate gene expression through the action of light. Whereas most methods target mRNAs, DNA decoys have recently been used to target DNA transcription by targeting specific DNA-transcription-factor interactions. This has allowed researchers to “turn-off” transcription through the action of light on caged nucleic acids for the first time.
- 23 January 2012
- Published by Wiley in ChemBioChem
- Vol. 13 (4) , 511-513
Photocaged DNA Provides New Levels of Transcription Control
Spot lit: Photocaged nucleic acids have been used to regulate gene expression through the action of light. Whereas most methods target mRNAs, DNA decoys have recently been used to target DNA transcription by targeting specific DNA-transcription-factor interactions. This has allowed researchers to “turn-off” transcription through the action of light on caged nucleic acids for the first time.
- 1 September 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (17) , 5258-5261
A mutant selective anti-estrogen is a pure antagonist on EREs and AP-1 response elements
- 1 September 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (17) , 5258-5261
A mutant selective anti-estrogen is a pure antagonist on EREs and AP-1 response elements
- 15 January 2010
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 5 (3) , 313-320
Light-Activated Gene Expression Directs Segregation of Co-cultured Cells in Vitro
Light-directed gene patterning methods have been described as a means to regulate gene expression in a spatially and temporally controlled manner. Several methods have been reported that use photocaged forms of small molecule effectors to control ligand-dependent transcription factors. Whereas these methods offer many advantages including high specificity and transient light-sensitivity, the free diffusion of the uncaged effector can limit both the magnitude and resolution of localized gene induction. Methods to date have been limited by the small fraction of irradiated cells that have expression levels significantly above uninduced background and have not been shown to affect a defined biological response. The tetracycline-dependent transactivator/transrepressor system, RetroTET-ART, combined with a photocaged form of doxycycline (NvOC-Dox) can be used to form photolithographic patterns of induced expression wherein up to 85% of the patterned cells show expression levels above uninduced regions. The efficiency and inducibility of the RetroTET-ART system allows one to quantitatively measure the limits of resolution and the relative induction levels mediated by a small molecule photocaged effector for the first time. Well-defined patterns of reporter genes were reproducibly formed within 6−36 h with feature sizes as small as 300 μm. After photo-patterning, NvOC-Dox can be rapidly removed, rendering cells photoinsensitive and allowing one to monitor GFP product formation in real time. Patterned co-expression of the cell surface ligand ephrin A5 on cell monolayers creates well-defined patterns that are sufficient to direct and segregate co-cultured cells via either attractive or repulsive signaling cues. The ability to direct the arrangement of cells on living cell monolayers through the action of light may serve as a model system for engineering artificial tissues.
- 15 January 2010
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 5 (3) , 313-320
Light-Activated Gene Expression Directs Segregation of Co-cultured Cells in Vitro
Light-directed gene patterning methods have been described as a means to regulate gene expression in a spatially and temporally controlled manner. Several methods have been reported that use photocaged forms of small molecule effectors to control ligand-dependent transcription factors. Whereas these methods offer many advantages including high specificity and transient light-sensitivity, the free diffusion of the uncaged effector can limit both the magnitude and resolution of localized gene induction. Methods to date have been limited by the small fraction of irradiated cells that have expression levels significantly above uninduced background and have not been shown to affect a defined biological response. The tetracycline-dependent transactivator/transrepressor system, RetroTET-ART, combined with a photocaged form of doxycycline (NvOC-Dox) can be used to form photolithographic patterns of induced expression wherein up to 85% of the patterned cells show expression levels above uninduced regions. The efficiency and inducibility of the RetroTET-ART system allows one to quantitatively measure the limits of resolution and the relative induction levels mediated by a small molecule photocaged effector for the first time. Well-defined patterns of reporter genes were reproducibly formed within 6−36 h with feature sizes as small as 300 μm. After photo-patterning, NvOC-Dox can be rapidly removed, rendering cells photoinsensitive and allowing one to monitor GFP product formation in real time. Patterned co-expression of the cell surface ligand ephrin A5 on cell monolayers creates well-defined patterns that are sufficient to direct and segregate co-cultured cells via either attractive or repulsive signaling cues. The ability to direct the arrangement of cells on living cell monolayers through the action of light may serve as a model system for engineering artificial tissues.
- 3 September 2008
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 47 (38) , 7280-7283
Selective Chemical Rescue of a Thyroid‐Hormone‐Receptor Mutant, TRβ(H435Y), Identified in Pituitary Carcinoma and Resistance to Thyroid Hormone
Ligand to the rescue! Thyroid hormone receptor (TR) plays a critical role in development and homeostasis. The mutant TRβ(H435Y) was identified in both cancer and resistance to thyroid hormone. A designed synthetic ligand recovered the cellular reporter-gene activity of TRβ(H435Y) with a 5 850-fold improvement in selectivity for the mutant relative to that of the natural hormone T3 (shown in a modeled structure with TRβ(H435Y)).
- 3 September 2008
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 47 (38) , 7280-7283
Selective Chemical Rescue of a Thyroid‐Hormone‐Receptor Mutant, TRβ(H435Y), Identified in Pituitary Carcinoma and Resistance to Thyroid Hormone
Ligand to the rescue! Thyroid hormone receptor (TR) plays a critical role in development and homeostasis. The mutant TRβ(H435Y) was identified in both cancer and resistance to thyroid hormone. A designed synthetic ligand recovered the cellular reporter-gene activity of TRβ(H435Y) with a 5 850-fold improvement in selectivity for the mutant relative to that of the natural hormone T3 (shown in a modeled structure with TRβ(H435Y)).
- 3 September 2008
- Published by Wiley in Angewandte Chemie
- Vol. 120 (38) , 7390-7393
Selective Chemical Rescue of a Thyroid‐Hormone‐Receptor Mutant, TRβ(H435Y), Identified in Pituitary Carcinoma and Resistance to Thyroid Hormone
- 3 September 2008
- Published by Wiley in Angewandte Chemie
- Vol. 120 (38) , 7390-7393
Selective Chemical Rescue of a Thyroid‐Hormone‐Receptor Mutant, TRβ(H435Y), Identified in Pituitary Carcinoma and Resistance to Thyroid Hormone
- 1 September 2007
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 2 (9) , 599-601
The New Biomimetic Chemistry: Artificial Transcription Factors
While many research programs have focused on the challenge of developing small molecules that can inhibit protein–protein interactions, some researchers have taken the problem one step further by attempting to develop small molecules that mimic the essential features of an entire protein. An area of particular interest has been in the field of artificial transcription factors (ATFs), where the essential function of some transcription factors is to recruit and promote the assembly of a larger transcription complex, leading to the expression of a gene of interest. The goal of synthesizing small-molecule ATFs holds promise as a means to independently control the expression of genes such as those that are misregulated in cancer and disease.
- 1 September 2007
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 2 (9) , 599-601
The New Biomimetic Chemistry: Artificial Transcription Factors
While many research programs have focused on the challenge of developing small molecules that can inhibit protein–protein interactions, some researchers have taken the problem one step further by attempting to develop small molecules that mimic the essential features of an entire protein. An area of particular interest has been in the field of artificial transcription factors (ATFs), where the essential function of some transcription factors is to recruit and promote the assembly of a larger transcription complex, leading to the expression of a gene of interest. The goal of synthesizing small-molecule ATFs holds promise as a means to independently control the expression of genes such as those that are misregulated in cancer and disease.
- 24 April 2007
- Published by Wiley in ChemBioChem
- Vol. 8 (7) , 799-803
Photocaged Agonist for an Analogue-Specific form of the Vitamin D Receptor
- 24 April 2007
- Published by Wiley in ChemBioChem
- Vol. 8 (7) , 799-803
Photocaged Agonist for an Analogue-Specific form of the Vitamin D Receptor
- 15 June 2006
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 128 (27) , 8868-8874
A Functionally Orthogonal Ligand−Receptor Pair Created by Targeting the Allosteric Mechanism of the Thyroid Hormone Receptor
Nuclear receptors are ligand-dependent transcription factors that are of interest as potential tools to artificially regulate gene expression. Ligand binding induces a conformational change involving helix-12 which forms part of the dimerization interface used to bind transcriptional coactivators. When triiodothyronine (T3) binds the thyroid hormone receptor (TR) it indirectly contacts helix-12 through intermediary residues His(435) and Phe(451) termed a His-Phe switch. The mutant TRβ(H435A) is nonresponsive to physiological concentrations of T3 but can be activated by the synthetic hormone analogue QH2 which potently activates His435→Ala mutant at concentrations that do not activate the wild-type receptors TRα and TRβ. QH2 does not show antagonist behavior with the wild-type TRs. QH2's functionally orthogonal behavior with TRβ(H435A) is preserved on the three consensus thyroid hormone response elements.
- 15 June 2006
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 128 (27) , 8868-8874
A Functionally Orthogonal Ligand−Receptor Pair Created by Targeting the Allosteric Mechanism of the Thyroid Hormone Receptor
Nuclear receptors are ligand-dependent transcription factors that are of interest as potential tools to artificially regulate gene expression. Ligand binding induces a conformational change involving helix-12 which forms part of the dimerization interface used to bind transcriptional coactivators. When triiodothyronine (T3) binds the thyroid hormone receptor (TR) it indirectly contacts helix-12 through intermediary residues His(435) and Phe(451) termed a His-Phe switch. The mutant TRβ(H435A) is nonresponsive to physiological concentrations of T3 but can be activated by the synthetic hormone analogue QH2 which potently activates His435→Ala mutant at concentrations that do not activate the wild-type receptors TRα and TRβ. QH2 does not show antagonist behavior with the wild-type TRs. QH2's functionally orthogonal behavior with TRβ(H435A) is preserved on the three consensus thyroid hormone response elements.